• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Willis Towers Watson Public Limited Company filed SEC Form 8-K: Results of Operations and Financial Condition, Regulation FD Disclosure, Financial Statements and Exhibits

    10/28/21 6:00:30 AM ET
    $WLTW
    Specialty Insurers
    Finance
    Get the next $WLTW alert in real time by email
    Form 8-K
    0001140536 False 0001140536 2021-10-28 2021-10-28 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

    _________________

    FORM 8-K

    _________________

    CURRENT REPORT

    Pursuant to Section 13 or 15(d)
    of the Securities Exchange Act of 1934

    Date of Report (Date of earliest event reported):  October 28, 2021

    _______________________________

    WILLIS TOWERS WATSON PLC

    (Exact name of registrant as specified in its charter)

    _______________________________

    Ireland001-1650398-0352587
    (State or Other Jurisdiction of Incorporation)(Commission File Number)(I.R.S. Employer Identification No.)

    c/o Willis Group Limited, 51 Lime Street, London, EC3M 7DQ, England and Wales

    (Address, including Zip Code, of Principal Executive Offices)

    Registrant's telephone number, including area code: (011) (44)-(20)-3124-6000

    Not Applicable

    (Former name or former address, if changed since last report)

    _______________________________

    Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

    ☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
    ☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
    ☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
    ☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

    Securities registered pursuant to Section 12(b) of the Act:

    Title of each classTrading Symbol(s)Name of each exchange on which registered
    Ordinary Shares, nominal value $0.000304635 per shareWLTWNASDAQ Global Select Market

    Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

    Emerging growth company ☐

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     
     
    Item 2.02. Results of Operations and Financial Condition.

    On October 28, 2021, Willis Towers Watson Public Limited Company (“Willis Towers Watson”) issued a press release announcing its financial results for the period ended September 30, 2021.

    A copy of Willis Towers Watson’s press release is attached hereto as an exhibit to this Current Report on Form 8-K and is incorporated by reference herein. A reconciliation between certain non-GAAP financial measures and reported financial results is provided as an attachment to the press release.

    Item 7.01. Regulation FD Disclosure.

    Willis Towers Watson also posted a slide presentation to its website, which it may refer to during its conference call to discuss the results. The slide presentation is attached hereto as Exhibit 99.2 and incorporated herein by reference.

    The information contained in Item 2.02 and Item 7.01 of this Current Report on Form 8-K (including Exhibits 99.1 and 99.2) is being furnished and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that section. Such information shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in any such filing.

    Item 9.01. Financial Statements and Exhibits.

    (d) Exhibits

    Exhibit No. Description
       
    99.1 Press release, dated October 28, 2021, announcing the financial results for the period ended September 30, 2021, for Willis Towers Watson Public Limited Company.  
    99.2 Slide Presentation, supplementing the above press release.
    104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
     
     

    SIGNATURE

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

     WILLIS TOWERS WATSON PLC
                  (Registrant)
       
      
    Date: October 28, 2021By: /s/ Matthew Furman         
     Name: Matthew Furman
     Title: General Counsel
      

     

    Get the next $WLTW alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $WLTW

    DatePrice TargetRatingAnalyst
    1/4/2022$280.00 → $284.00Overweight
    Wells Fargo
    12/16/2021$240.00In-Line
    Evercore ISI Group
    11/19/2021$258.00Hold
    Jefferies
    10/29/2021$266.00 → $280.00Overweight
    Wells Fargo
    10/20/2021$283.00 → $244.00Outperform → Peer Perform
    Wolfe Research
    9/10/2021$250.00 → $285.00Buy
    MKM Partners
    9/10/2021$220.00 → $235.00Neutral
    Piper Sandler
    8/17/2021$261.00Outperform
    Wolfe Research
    More analyst ratings